Vascular Medicine最新文献_第5页

Comparing DOAC and warfarin outcomes in an obese population using the 'real-world' Michigan Anticoagulation Quality Improvement Initiative (MAQI²) registry. 利用 "真实世界 "密歇根抗凝质量改进倡议（MAQI2）登记比较肥胖人群中 DOAC 和华法林的疗效。

IF 3 3区医学

Vascular Medicine Pub Date : 2024-10-01 Epub Date: 2024-08-23 DOI: 10.1177/1358863X241264478

Nelish Ardeshna, Thane Feldeisen, Xiaowen Kong, Brian Haymart, Scott Kaatz, Mona Ali, Geoffrey D Barnes, James B Froehlich

{"title":"Comparing DOAC and warfarin outcomes in an obese population using the 'real-world' Michigan Anticoagulation Quality Improvement Initiative (MAQI2) registry.","authors":"Nelish Ardeshna, Thane Feldeisen, Xiaowen Kong, Brian Haymart, Scott Kaatz, Mona Ali, Geoffrey D Barnes, James B Froehlich","doi":"10.1177/1358863X241264478","DOIUrl":"10.1177/1358863X241264478","url":null,"abstract":"Introduction: Direct oral anticoagulants (DOACs) have overtaken warfarin in the treatment of nonvalvular atrial fibrillation (AF) and venous thromboembolism (VTE). Limited data explore the safety of DOACs in obesity.Methods: This multicenter retrospective study between June 2015 and September 2019 uses the Michigan Anticoagulation Quality Improvement Initiative (MAQI2) registry to compare DOACs and warfarin across weight classes (not obese: body mass index (BMI) ⩾ 18.5 and < 30; obese: BMI ⩾ 30 and < 40; severely obese: BMI ⩾ 40). Primary outcomes include major, clinically relevant nonmajor (CRNM), and minor bleeding events per 100 patient-years. Secondary outcomes include stroke, recurrent VTE, and all-cause mortality.Results: DOACs were prescribed to 49% of the 4089 patients with AF and 46% of the 3162 patients with VTE. Compared to patients treated with warfarin, those treated with DOACs had a higher estimated glomerular filtration rate across BMI categories regardless of indication. In the AF population, severely obese patients treated with DOACs had more major (3.4 vs 1.8, p = 0.004), CRNM (8.6 vs 5.9, p = 0.019), and minor bleeding (11.4 vs 9.9, p = 0.001). There was no difference in stroke or all-cause mortality. In the VTE population, both CRNM (7.5 vs 6.7, p = 0.042) and minor bleeding (19.3 vs 10.5, p < 0.001) events occurred at higher rates in patients treated with DOACs. There was no difference in recurrent pulmonary embolism, stroke, or all-cause mortality.Conclusion: There is a higher rate of bleeding in severely obese patients with VTE and AF treated with DOACs compared to warfarin, without a difference in secondary outcomes. Further studies to compare the anticoagulant classes and understand bleeding drivers in this population are needed.","PeriodicalId":23604,"journal":{"name":"Vascular Medicine","volume":" ","pages":"543-552"},"PeriodicalIF":3.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142037067","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Celiac truncus agenesis with median arcuate ligament syndrome. 血管医学图像：伴有正中弓状韧带综合征的腹腔盲端。

IF 3 3区医学

Vascular Medicine Pub Date : 2024-10-01 Epub Date: 2024-09-04 DOI: 10.1177/1358863X241265662

Osman Öcal, Matthias P Fabritius

引用次数: 0

Pulmonary hypertension-related deaths in patients with acute pulmonary embolism in the United States, 2003 to 2020. 2003 至 2020 年美国急性肺栓塞患者中与肺动脉高压相关的死亡人数。

IF 3 3区医学

Vascular Medicine Pub Date : 2024-10-01 Epub Date: 2024-08-07 DOI: 10.1177/1358863X241257165

Marco Zuin, Roberto Badagliacca, Eileen Harder, Bridget McGonagle, Christie Greason, Gregory Piazza

{"title":"Pulmonary hypertension-related deaths in patients with acute pulmonary embolism in the United States, 2003 to 2020.","authors":"Marco Zuin, Roberto Badagliacca, Eileen Harder, Bridget McGonagle, Christie Greason, Gregory Piazza","doi":"10.1177/1358863X241257165","DOIUrl":"10.1177/1358863X241257165","url":null,"abstract":"Background: Data regarding the mortality trends in pulmonary embolism (PE)-related mortality in patients with concomitant pulmonary hypertension (PH) are lacking. We assessed the trends in PE-related mortality in patients with concomitant PH in the United States (US) over the past 2 decades and during the first year of the COVID-19 pandemic using data from the Centers for Disease Control and Prevention's (CDC) Wide-ranging ONline Data for Epidemiologic Research (WONDER) dataset.Methods: Mortality data were retrieved from the publicly available CDC WONDER mortality dataset from 2003 to 2020. Age-adjusted mortality rates (AAMRs), per 100,000 population, were assessed using Joinpoint regression modelling and expressed as estimated average annual percentage change (AAPC) with relative 95% CIs and stratified by urbanicity, sex, age, and race/ethnicity.Results: Over the study period, the AAMR for PE/PH-related mortality linearly increased (AAPC: +4.3% [95% CI: 3.7 to 4.9], p < 0.001) without sex differences. The AAMR increase was more pronounced in White individuals (AAPC: +4.8% [95% CI: 4.1 to 5.5], p < 0.001) and in subjects living in rural areas (AAPC: +5.1% [95% CI: 3.8 to 6.4], p < 0.001) compared to those living in urban areas. During the first year of the COVID-19 pandemic there was a significant excess in PE/PH-related mortality among women, older than 65 years and living in rural areas.Conclusions: The rate of PE/PH-related mortality in the US is increasing. Although the early diagnosis of PH in patients with acute PE has become easier with improved diagnostic modalities, the mortality rate of these patients remains high.","PeriodicalId":23604,"journal":{"name":"Vascular Medicine","volume":" ","pages":"534-542"},"PeriodicalIF":3.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141898370","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Underutilization of supervised exercise therapy for symptomatic peripheral artery disease among Medicare beneficiaries. 医疗保险受益人对有症状外周动脉疾病的监督运动疗法利用不足。

IF 3 3区医学

Vascular Medicine Pub Date : 2024-10-01 Epub Date: 2024-08-12 DOI: 10.1177/1358863X241266859

Sanjay Divakaran, Siling Li, Yang Song, Anna K Krawisz, Brett J Carroll, Eric A Secemsky

引用次数: 0

Executive Summary of Standard Operating Procedures for Society for Vascular Medicine (SVM) publications. 血管医学学会 (SVM) 出版物标准操作程序执行摘要。

IF 3 3区医学

Vascular Medicine Pub Date : 2024-10-01 Epub Date: 2024-08-23 DOI: 10.1177/1358863X241268661

Carlos Mena-Hurtado, Herbert D Aronow, Joshua Beckman, Behnood Bikdeli, Ulf Bronas, Yulanka Castro-Dominguez, Saurav Chatterjee, Islam Y Elgendy, Daniella Kadian-Dodov, Shea Hogan, Sanjum Sethi, Farina Mohamad Yusoff, Debabrata Mukherjee

引用次数: 0

Society Communications: 2024 Committee Updates. 学会通讯：2024 委员会更新。

IF 3 3区医学

Vascular Medicine Pub Date : 2024-10-01 Epub Date: 2024-09-06 DOI: 10.1177/1358863X241268675

Kevin P Cohoon, Daniella Kadian-Dodov, Robert Eberhardt, Aditya Sharma

引用次数: 0

Cerebral infarction secondary to traumatic external carotid artery dissection. 血管医学影像：外伤性颈外动脉夹层继发脑梗塞。

IF 3 3区医学

Vascular Medicine Pub Date : 2024-10-01 Epub Date: 2024-05-16 DOI: 10.1177/1358863X241250321

Siran Zhang, Xiya Li, Qiao Zhou, Guangsen Li

引用次数: 0

Geographical disparities in access to surgical treatment and mortality rates from abdominal aortic aneurysms in Brazil: A retrospective longitudinal study. 巴西腹主动脉瘤手术治疗机会和死亡率的地域差异：回顾性纵向研究。

IF 3 3区医学

Vascular Medicine Pub Date : 2024-10-01 Epub Date: 2024-06-11 DOI: 10.1177/1358863X241253732

Rogério do Lago Franco, Pedro Henrique Iora, Miyoko Massago, Matheus Henrique Arruda Beltrame, Ualid Saleh Hatoum, Vinicius Giacomin, Isadora Martins Borba, Sérgio Quilici Belczak, Catherine Ann Staton, Amanda de Carvalho Dutra, Luciano de Andrade

{"title":"Geographical disparities in access to surgical treatment and mortality rates from abdominal aortic aneurysms in Brazil: A retrospective longitudinal study.","authors":"Rogério do Lago Franco, Pedro Henrique Iora, Miyoko Massago, Matheus Henrique Arruda Beltrame, Ualid Saleh Hatoum, Vinicius Giacomin, Isadora Martins Borba, Sérgio Quilici Belczak, Catherine Ann Staton, Amanda de Carvalho Dutra, Luciano de Andrade","doi":"10.1177/1358863X241253732","DOIUrl":"10.1177/1358863X241253732","url":null,"abstract":"Introduction: Abdominal aortic aneurysm (AAA) is a growing public health problem, and not all patients have access to surgery when needed. This study aimed to analyze spatiotemporal variations in AAA mortality and surgical procedures in Brazilian intermediate geographic regions and explore the impact of different surgical techniques on operative mortality.Methods: A retrospective longitudinal study was conducted to evaluate AAA mortality from 2008 to 2020 using space-time cube (STC) analysis and the emerging hot spot analysis tool through the Getis-Ord Gi* method.Results: There were 34,255 deaths due to AAA, 13,075 surgeries to repair AAA, and a surgical mortality of 14.92%. STC analysis revealed an increase in AAA mortality rates (trend statistic = +1.7693, p = 0.0769) and a significant reduction in AAA surgery rates (trend statistic = -3.8436, p = 0.0001). Analysis of emerging hotspots revealed high AAA mortality rates in the South, Southeast, and Central-West, with a reduction in procedures in São Paulo and Minas Gerais States (Southeast). In the Northeast, there were extensive areas of increasing mortality rates and decreasing procedure rates (cold spots).Conclusion: AAA mortality increased in several regions of the country while surgery rates decreased, demonstrating the need for implementing public health policies to increase the availability of surgical procedures, particularly in less developed regions with limited access to services.","PeriodicalId":23604,"journal":{"name":"Vascular Medicine","volume":" ","pages":"526-531"},"PeriodicalIF":3.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141301736","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Solving the Rubik's Cube of AAA mortality in Brazil using space-time cube analysis. 利用时空立方体分析解决巴西 AAA 死亡率的魔方问题。

IF 3 3区医学

Vascular Medicine Pub Date : 2024-10-01 Epub Date: 2024-06-16 DOI: 10.1177/1358863X241254799

Craig S Brown, Oscar Moreno Rocha, Andrea T Obi

引用次数: 0

Efficacy and safety of aspirin plus clopidogrel versus aspirin alone in ischemic stroke or high-risk transient ischemic attack: A meta-analysis of randomized controlled trials. 阿司匹林加氯吡格雷与单用阿司匹林治疗缺血性中风或高危短暂性脑缺血发作的疗效和安全性：随机对照试验荟萃分析。

IF 3 3区医学

Vascular Medicine Pub Date : 2024-10-01 Epub Date: 2024-08-20 DOI: 10.1177/1358863X241265335

Mushood Ahmed, Areeba Ahsan, Laveeza Fatima, Jawad Basit, Abdulqadir J Nashwan, Shafaqat Ali, Mohammad Hamza, Iosif Karalis, Raheel Ahmed, Ahmad Alareed, Nkechinyere N Ijioma, M Chadi Alraies

{"title":"Efficacy and safety of aspirin plus clopidogrel versus aspirin alone in ischemic stroke or high-risk transient ischemic attack: A meta-analysis of randomized controlled trials.","authors":"Mushood Ahmed, Areeba Ahsan, Laveeza Fatima, Jawad Basit, Abdulqadir J Nashwan, Shafaqat Ali, Mohammad Hamza, Iosif Karalis, Raheel Ahmed, Ahmad Alareed, Nkechinyere N Ijioma, M Chadi Alraies","doi":"10.1177/1358863X241265335","DOIUrl":"10.1177/1358863X241265335","url":null,"abstract":"Background: Antiplatelet therapy plays an important role in reducing the risk of stroke recurrence in patients with mild ischemic stroke or high-risk transient ischemic attack (TIA). However, data regarding the effectiveness and safety of using aspirin plus clopidogrel in dual antiplatelet therapy (DAPT) compared to aspirin alone in mild ischemic stroke is limited. Methods: PubMed/MEDLINE, Embase, Cochrane Library, and ClinicalTrials.gov were searched for randomized controlled trials (RCTs) that compared DAPT to aspirin alone started within 72 hours in mild ischemic stroke or high-risk TIA. We used a random effects model to pool risk ratios (RRs) along with 95% CIs for clinical outcomes. Results: Four RCTs with 16,547 patients were included in this study. DAPT significantly reduced the risk of recurrent stroke by 26% (RR: 0.74; 95% CI: 0.67-0.83; p < 0.00001), ischemic stroke by 28% (RR: 0.72; 95% CI: 0.65-0.80; p < 0.00001), and major adverse cardiovascular events (MACE) by 24% (RR: 0.76; 95% CI: 0.68-0.84; p < 0.00001) compared to aspirin monotherapy. However, DAPT was associated with a significantly increased risk of moderate or severe bleeding (RR: 1.88; 95% CI: 1.10-3.23; p = 0.02) compared to aspirin alone. No significant differences were observed for hemorrhagic stroke (RR: 1.77; 95% CI: 0.96-3.29; p = 0.07), all-cause mortality (RR: 1.25; 95% CI: 0.87-1.80; p = 0.23), cardiovascular mortality (RR: 1.38; 95% CI: 0.81-2.33; p = 0.23), and myocardial infarction (RR: 1.63; 95% CI: 0.77-3.46; p = 0.20). Conclusion: DAPT involving aspirin plus clopidogrel reduces stroke recurrence and MACE but can lead to an increased risk of moderate or severe bleeding compared to aspirin monotherapy. (PROSPERO ID: CRD42024499310).","PeriodicalId":23604,"journal":{"name":"Vascular Medicine","volume":" ","pages":"517-525"},"PeriodicalIF":3.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142009572","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0